News
New Impact Factor of
According to the latest "Journal
Citation Reports" list, published on 20 June 2024, "Pharmacological
Reports"
obtained an Impact Factor of 3.6
(five-year Impact Factor = 3.2).
The journal was ranked in the second quartile (Q2) in the field
"PHARMACOLOGY & PHARMACY". Despite the decrease in the Impact
Factor value compared to last year, which reflects the downward trend
recorded in the case of most journals (the effect of changes in the citation
rules introduced by Clarivate and less frequently cited articles on COVID-19),
"Pharmacological Reports" improved its position among journals in
this scientific category - 73.6 percentile - the highest position recorded in
the history of the journal.
We would like to thank the Editorial Team, Associate Editors, Reviewers and Authors
for their cooperation, and efforts to ensure the high quality of the journal
and for contributing to its constant development. Readers and potential Authors
are invited to submit articles for publication, as well as to submit topics and
collaborate on special issues of the journal.
Open lecture on March 27, 2024 - Prof. Emanuele Amata Ph.D
We are honored to invite you to an open lecture scheduled to take
place in the conference hall of IF PAN at 11 a.m. on the 27th of March, 2024.
The lecture, entitled: Development of Sigma Receptor modulator as
non-opioid/non-narcotic agents for the treatment of Neuropathic Pain,
will be delivered by Prof. Emanuele
Amata Ph.D. from the University of
Catania.
Lecture 6th of March, 2024 11 a.m. Bogna Ignatowska-Jankowska, PhD
We are honored to invite you to an open lecture
scheduled to take place in the conference hall of IF PAN at 11 a.m. on the 6th
of March, 2024. The lecture, entitled Distinct behavioral phenotypes
induced by endocannabinoid modulation in high-precision 3D motion capture of
freely moving mice, will be delivered by Bogna Ignatowska-Jankowska,
PhD from the Okinawa Institute of Science and Technology.
"ROS-Scavenging Magnetic Nanozymes with Remote Activation for Alzheimer Disease" (ROSSCA) as part of the M-ERA.NET Call 2023 competition, in the "Advanced materials and technologies for health applications"
We are pleased to announce that the project is implemented by an international consortium composed of 4 partners with skills and experience in the field of physics and materials science, genetic toxicology, molecular biology and neuropsychopharmacology. Ph.D. Anna Haduch, as the task manager, received funding for an international project entitled "ROS-Scavenging Magnetic Nanozymes with Remote Activation for Alzheimer Disease" (ROSSCA) as part of the M-ERA.NET Call 2023 competition, in the "Advanced materials and technologies for health applications" category. The competition was organized by the M-ERA.NET 3 network, which supports international research projects in materials science and engineering.
